Orthopedic Companies Report Results for First Quarter 2024
Stay up to date on the orthopedic market's 1Q performance in 2024 as we update this post with company sales data and industry developments. May 28, 2024
How Medacta Continues to Drive Above-Market Growth
We spoke with Medacta CEO Francesco Siccardi about what is driving the company’s strong sales, knee replacement market shifts and orthopedic market opportunities. May 23, 2024
What Market Drivers Are Shaping Orthopedics?
Our latest video explores the trends and forecasts shaping the orthopedic industry as it drives to $70 billion in sales in 2027. May 16, 2024
Enovis on Track for $1 Billion Recon Business
Enovis' reconstructive segment accounted for just 22% of sales in 2019. It will account for nearly 50% as it reaches $1 billion in 2024. May 15, 2024
OrthoPediatrics Reports Improving Surgical Environment
The company's orthopedic sales grew more than 22% in 1Q24 as volume and staffing improve in the pediatric market. May 15, 2024
Anika Therapeutics Reiterates 2024 Guide, Cuts Costs
The company's orthopedic sales grew in the mid-single-digits during 1Q24 as the company reduced headcount to control costs. May 14, 2024
Vericel Keeps Momentum Ahead of MACI Arthro Launch
The company's MACI sales grew nearly 18% in the first quarter of 2024 with the launch of MACI Arthro expected in the third quarter. May 14, 2024
Paragon 28 Takes Sequential Step Up in Record Quarter
The company grew more than 17% in the first quarter of 2024 despite a difficult comparison and one less selling day. May 13, 2024
Treace Medical Reduces 2024 Guide on Competitive Headwinds
The company grew more than 20% in the first quarter of 2024 but lowered its full-year guidance due to increased competitive headwinds. May 13, 2024
ATEC Sees Market Disruption As Long Tail Growth Driver
The company grew 27% in the first quarter of 2024 as it further capitalized on disruption in the spine market. May 10, 2024
